Stanley-Laman Group
LLY icon

Stanley-Laman Group’s Eli Lilly LLY Stock Holding History

Stanley-Laman Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.68M Sell
6,638
-109
-2% -$129K 0.84% 28
2026
Q2 		$8.09M Sell
6,747
-40
-0.6% -$40.9K 0.82% 30
2026
Q1 		$6.24M Buy
6,787
+322
+5% +$326K 0.77% 31
2025
Q4 		$6.95M Buy
6,465
+2,665
+70% +$2.55M 0.88% 24
2025
Q3 		$2.9M Sell
3,800
-169
-4% -$126K 0.41% 93
2025
Q2 		$3.09M Sell
3,969
-1,493
-27% -$1.16M 0.46% 99
2025
Q1 		$4.51M Buy
5,462
+185
+4% +$154K 0.69% 48
2024
Q4 		$4.07M Sell
5,277
-3
-0.1% -$2.48K 0.57% 71
2024
Q3 		$4.68M Sell
5,280
-103
-2% -$92.6K 0.66% 51
2024
Q2 		$4.87M Sell
5,383
-4,438
-45% -$3.55M 0.7% 42
2024
Q1 		$7.64M Sell
9,821
-2,073
-17% -$1.48M 1.07% 15
2023
Q4 		$6.93M Sell
11,894
-1,558
-12% -$909K 1.06% 26
2023
Q3 		$7.23M Sell
13,452
-597
-4% -$308K 1.23% 13
2023
Q2 		$6.59M Sell
14,049
-1,678
-11% -$704K 1.09% 20
2023
Q1 		$5.4M Sell
15,727
-122
-0.8% -$41.1K 0.96% 23
2022
Q4 		$5.8M Sell
15,849
-662
-4% -$235K 1.1% 15
2022
Q3 		$5.34M Sell
16,511
-802
-5% -$254K 1.01% 22
2022
Q2 		$5.61M Sell
17,313
-1,689
-9% -$507K 1% 21
2022
Q1 		$5.44M Buy
19,002
+2,350
+14% +$605K 0.75% 31
2021
Q4 		$4.6M Buy
16,652
+1,422
+9% +$360K 0.54% 48
2021
Q3 		$3.52M Buy
15,230
+1,261
+9% +$311K 0.46% 49
2021
Q2 		$3.21M Buy
13,969
+1,304
+10% +$262K 0.46% 49
2021
Q1 		$2.37M Buy
12,665
+754
+6% +$147K 0.39% 62
2020
Q4 		$2.01M Sell
11,911
-617
-5% -$92.1K 0.36% 70
2020
Q3 		$1.85M Buy
+12,528
New +$1.94M 0.41% 64
2020
Q2 		– Sell
-2,002
Closed -$278K – 248
2020
Q1 		$278K Buy
+2,002
New +$275K 0.08% 206
2014
Q1 		– Sell
-29,601
Closed -$1.51M – 329
2013
Q4 		$1.51M Buy
+29,601
New +$1.48M 0.33% 96

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return
Goelzer Investment Management
Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return
Private Capital Advisors
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Weatherly Asset Management
Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return

Stanley-Laman Group's LLY Position: Q3 2026 in Review

Stanley-Laman Group reduced its Eli Lilly (LLY) stake by 1.6% in Q3 2026, selling an estimated $129K and leaving 6,638 shares worth $7.68M. The position accounts for 0.84% of the portfolio, ranked #28.

Stanley-Laman Group first reported a position in LLY in Q4 2013 and has held it in 27 quarters since. The position peaked at $8.09M in Q2 2026. 1,134 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Stanley-Laman Group held 6,638 shares of Eli Lilly worth $7.68M as of Q3 2026.
  • Stanley-Laman Group sold 109 Eli Lilly shares in Q3 2026, an estimated $129K.
  • Eli Lilly made up 0.84% of Stanley-Laman Group's portfolio in Q3 2026, its #28 holding.
  • Stanley-Laman Group first reported a position in Eli Lilly in Q4 2013 and has held it in 27 quarters since.
  • Stanley-Laman Group's Eli Lilly position peaked at $8.09M in Q2 2026.
  • 1,134 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Stanley-Laman Group's 13F filing for Q3 2026, filed 20 Oct 2026.